REX to exhibit at the Hamlyn Symposium on Medical Robots
Released : 10 July 2014
Link here.
REX to exhibit at the Hamlyn Symposium on Medical Robots
Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use by wheelchair users, announces that it will be exhibiting at the 7th Hamlyn Symposium on Medical Robots, at the Royal Geographical Society, London, from July 13th to July 15th 2014.
The Hamlyn Centre for Robots Surgery was established for developing safe, effective and accessible technologies that can reshape the future of healthcare for both developing and developed countries. Focusing on technological innovation, but with a strong emphasis on clinical translation and direct patient benefit with a global impact, the centre is at the forefront of research in imaging, sensing and robotics for addressing global health challenges associated with demographic, environment, social and economic changes.
The Hamlyn Symposium, chaired by Lord Darzi of Denham and Professor Guang-Zhong Yang, of Imperial College, grew out of the original Imperial College’s Cross Faculty Workshops on Medical Robotics funded by the Hamlyn Centre for Robotic Surgery and is now established as an annual international forum for clinicians, engineers and researchers to exchange ideas and explore new challenges and opportunities in healthcare technologies.
During the Symposium, REX Bionics’ brand ambassador, Sophie Morgan, will demonstrate the benefits of REX for wheelchair users, in addition to highlighting the applicability to REX as a tool for researchers & engineers.
Jeremy Curnock Cook, Chief Executive of Rex Bionics, commented: “The Hamlyn Symposium is at the forefront of collaboration between those at the cutting edge of technology design for medical robots and Rex Bionics is delighted to have the opportunity to showcase REX at this event.
“As REX launches in Europe, we welcome the opportunity to demonstrate the unique hands-free exoskeleton to such a prestigious audience.”
—
For further information please contact:
Rex Bionics Plc
Jeremy Curnock Cook, Chief Executive Officer
+44 (0) 781 086 6386
Peter Worrall, Chief Financial Officer
+44 (0)1428 645416
Oriel Securities Limited (NOMAD and Broker)
Juliet Thompson/Jonathan Senior
+44 (0) 20 7710 7600
Consilium Strategic Communications
Mary-Jane Elliott / Emma Thompson / Jessica Hodgson / Lindsey Neville
rexbionics@consilium-comms.com
+44 (0) 203 709 5700
About Rex Bionics
Rex Bionics (AIM: RXB) is an AIM-listed developer and manufacturer of REX products, hands-free robotic exoskeletons for use by people with mobility impairments. Founded in Auckland, New Zealand by two robotics engineers with first-hand experience of wheelchair users and their needs, Rex Bionics focuses on products designed to enable wheelchair users to stand and walk autonomously without the need for crutches or supports and is the only company to produce hands-free walking devices for wheelchair users. Rex Bionics’ marketed products: REX Rehab and REX Personal, can be used by people with complete spinal cord injury, but also by a much broader potential customer base, including people with multiple sclerosis and muscular dystrophy. In May 2014, Rex Bionics joined AIM with a fundraising of £10 million (gross) to scale up production, distribution and marketing internationally, in order to support growing demand for both REX products as well as developing the next generation of REX devices, REX 3.
For more information please visit, www.rexbionics.com